Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro

BACKGROUND: Merkel cell carcinoma (MCC) is a highly malignant skin cancer. Despite major treatment improvements during the last decade, up to 50% of patients do not respond to therapy or develop recurrent disease. For these patients, alternative treatment options are urgently needed. Here, we assess...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Med Oncol
Hlavní autoři: Chteinberg, Emil, Wetzels, Suzan, Gerritsen, Wouter, Temmerman, Lieve, van den Oord, Joost, Biessen, Erik, Kurz, Anna Kordelia, Winnepenninckx, Véronique, Zenke, Martin, Speel, Ernst-Jan, zur Hausen, Axel
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7739210/
https://ncbi.nlm.nih.gov/pubmed/33403016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920975621
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky